TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Panafarma Medical Consult AB
Closing information (x1000 DKK)
| Closing information | 2024/06 | 2023/06 | 2022/06 |
| Turnover |
158
|
189
|
267 |
| Financial expenses |
0
|
0
|
1 |
| Earnings before taxes |
1
|
33
|
22 |
| EBITDA |
-3
|
33
|
22 |
| Total assets |
244
|
232
|
318 |
| Current assets |
244
|
231
|
317 |
| Current liabilities |
81
|
75
|
139 |
| Equity capital |
152
|
147
|
169 |
| - share capital |
66
|
63
|
70 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Solvency |
62.3%
|
63.4%
|
53.1% |
| Turnover per employee |
79
|
94
|
134 |
| Profit as a percentage of turnover |
0.6%
|
17.5%
|
8.2% |
| Return on assets (ROA) |
0.4%
|
14.2%
|
7.2% |
| Current ratio |
301.2%
|
308.0%
|
228.1% |
| Return on equity (ROE) |
0.7%
|
22.4%
|
13.0% |
| Change turnover |
-39
|
-52
|
26 |
| Change turnover % |
-20%
|
-22%
|
11% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/06 | 2023/06 | 2022/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.